Didcot, United Kingdom

Meike Roskamp

This inventor holds 1 USPTO granted patent. Top assignee: Midatech Limited. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Meike Roskamp. Retrieved from https://idiyas.com/inventor/meike-roskamp-y20yt6mr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Meike Roskamp: Innovator in Cancer Therapy

Introduction

Meike Roskamp is a prominent inventor based in Didcot, GB. She has made significant contributions to the field of cancer therapy through her innovative research and development of nanoparticles. Her work focuses on creating effective treatments for skin cancer, showcasing her dedication to advancing medical science.

Latest Patents

Meike Roskamp holds a patent for her invention titled "Nanoparticles and their use in cancer therapy." This patent describes a nanoparticle that comprises a core made of metal and a corona consisting of various ligands covalently linked to the core. The ligands include a first species with an ethylene glycol portion and an amine group, as well as a second species featuring a carbohydrate group. This invention is particularly aimed at treating cancer, especially skin cancer, in mammalian subjects. The patent also outlines methods of treatment that involve administering the nanoparticles either alone or in combination with radiotherapy.

Career Highlights

Throughout her career, Meike has been associated with Midatech Limited, where she has been instrumental in developing innovative solutions for cancer treatment. Her work has not only contributed to the scientific community but has also paved the way for new therapeutic approaches in oncology.

Collaborations

Meike Roskamp has collaborated with notable colleagues, including Jon Golding and Phillip Williams. These partnerships have enhanced her research efforts and contributed to the advancement of her innovative projects.

Conclusion

Meike Roskamp's contributions to cancer therapy through her patented nanoparticles demonstrate her commitment to improving medical treatments. Her work continues to inspire advancements in the field of oncology, making a significant impact on patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…